Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

179 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The experience of re-infection among people who inject drugs successfully treated for hepatitis C.
Karasz A, Merchant K, Singh R, Thomas A, Borsuk C, McKee D, Duryea P, Kim AY, Mehta S, Norton BL, Page K, Pericot-Valverde I, Sedillo S, Stein ES, Taylor LE, Tsui J, Litwin A. Karasz A, et al. Among authors: taylor le. J Subst Use Addict Treat. 2023 Mar;146:208937. doi: 10.1016/j.josat.2022.208937. Epub 2023 Jan 6. J Subst Use Addict Treat. 2023. PMID: 36880897
Recommendations for the management of hepatitis C virus infection among people who inject drugs.
Robaeys G, Grebely J, Mauss S, Bruggmann P, Moussalli J, De Gottardi A, Swan T, Arain A, Kautz A, Stöver H, Wedemeyer H, Schaefer M, Taylor L, Backmund M, Dalgard O, Prins M, Dore GJ; International Network on Hepatitis in Substance Users. Robaeys G, et al. Clin Infect Dis. 2013 Aug;57 Suppl 2:S129-37. doi: 10.1093/cid/cit302. Clin Infect Dis. 2013. PMID: 23884061
Excluding people who use drugs or alcohol from access to hepatitis C treatments – Is this fair, given the available data?
Grebely J, Haire B, Taylor LE, Macneill P, Litwin AH, Swan T, Byrne J, Levin J, Bruggmann P, Dore GJ; International Network for Hepatitis in Substance Users. Grebely J, et al. Among authors: taylor le. J Hepatol. 2015 Oct;63(4):779-82. doi: 10.1016/j.jhep.2015.06.014. Epub 2015 Aug 4. J Hepatol. 2015. PMID: 26254264 Free PMC article. No abstract available.
Recommendations for the management of hepatitis C virus infection among people who inject drugs.
Grebely J, Robaeys G, Bruggmann P, Aghemo A, Backmund M, Bruneau J, Byrne J, Dalgard O, Feld JJ, Hellard M, Hickman M, Kautz A, Litwin A, Lloyd AR, Mauss S, Prins M, Swan T, Schaefer M, Taylor LE, Dore GJ; International Network for Hepatitis in Substance Users. Grebely J, et al. Among authors: taylor le. Int J Drug Policy. 2015 Oct;26(10):1028-38. doi: 10.1016/j.drugpo.2015.07.005. Epub 2015 Jul 17. Int J Drug Policy. 2015. PMID: 26282715 Free PMC article.
Empfehlungen zur Hepatitis Versorgung bei Drogenkonsumierenden.
Grebely J, Robaeys G, Bruggmann P, Aghemo A, Backmund M, Bruneau J, Byrne J, Dalgard O, Feld JJ, Hellard M, Hickman M, Kautz A, Litwin A, Lloyd AR, Mauss S, Prins M, Swan T, Schaefer M, Taylor LE, Dore GJ; im Namen vom International Network on Hepatitis care in Substance Users. Grebely J, et al. Among authors: taylor le. Int J Drug Policy. 2023 Jan;111:101670. doi: 10.1016/j.drugpo.2015.11.010. Epub 2015 Nov 28. Int J Drug Policy. 2023. PMID: 26749563 No abstract available.
Rationale and design of a randomized pragmatic trial of patient-centered models of hepatitis C treatment for people who inject drugs: The HERO study.
Litwin AH, Jost J, Wagner K, Heo M, Karasz A, Feinberg J, Kim AY, Lum PJ, Mehta SH, Taylor LE, Tsui JI, Pericot-Valverde I, Page K; HERO Study Group. Litwin AH, et al. Among authors: taylor le. Contemp Clin Trials. 2019 Dec;87:105859. doi: 10.1016/j.cct.2019.105859. Epub 2019 Oct 24. Contemp Clin Trials. 2019. PMID: 31669450 Free PMC article.
Patient-centred models of hepatitis C treatment for people who inject drugs: a multicentre, pragmatic randomised trial.
Litwin AH, Lum PJ, Taylor LE, Mehta SH, Tsui JI, Feinberg J, Kim AY, Norton BL, Heo M, Arnsten J, Meissner P, Karasz A, Mckee MD, Ward JW, Johnson N, Pericot-Valverde I, Agyemang L, Stein ES, Thomas A, Borsuk C, Blalock KL, Wilkinson S, Wagner K, Roche J, Murray-Krezan C, Anderson J, Jacobsohn V, Luetkemeyer AF, Falade-Nwulia O, Page K; HERO Study Group. Litwin AH, et al. Among authors: taylor le. Lancet Gastroenterol Hepatol. 2022 Dec;7(12):1112-1127. doi: 10.1016/S2468-1253(22)00275-8. Lancet Gastroenterol Hepatol. 2022. PMID: 36370741 Clinical Trial.
179 results